Before now, the fluid surrounding the brain was generally considered to be a sort of salt-solution that simply maintained the brain's ionic balance. Recent reports of fluctuating proteins in the fluid suggested otherwise, however.
And thus, a multi-institutional research teams at the Children's Hospital in Boston, led by Maria Lehtinen, Mauro Zappaterra and Christopher Walsh and researchers from the George Washington University School of Medicine and Health Sciences in Washington, D.C., decided to take a closer look at what proteins in the fluid do. What they found shocked them: As embryos and their brains are growing, a type of protein that tells brain cells to multiply increases in the so-called cerebrospinal fluid.
"This study is a game changer," says Anthony LaMantia, director of the GW Institute for Neuroscience at the GW School of Medicine and Health Sciences and an author on the paper, along with Thomas Maynard, Associate Professor of Pharmacology and Physiology at GW. "It's remarkable that signals are coming from the cerebrospinal fluid – it makes sense but no one really thought about it in this way."
Brain cells in the cortex -- the part of the brain responsible for cognition, learning and memory -- multiply and move to their appropriate position between the second and third trimester of embryonic development in humans. But until now, researchers have had little luck finding the molecular signals that direct the process as well as determining how the signals get delivered to the cells that need them.
The current team extracted cerebrospinal fluid from mouse embryos around two weeks after conception, when their brains develop most quickly. The fluid contained high levels of a protein, insulin-like growth factor or Igf2, which is known to help stem cells multiply and differentiate. Notably, the protein isn't elevated after birth. When the authors blocked Igf2, stem cells in the brain stopped making brain cells, which resulted in abnormally tiny mice brains. And when the team placed brain stem cells in a dish filled with Igf2-rich, embryonic cerebrospinal fluid, the cells proliferated rapidly. "This was clearly the environment the stem cells needed to be happy," LaMantia explains.
Brain cell proliferation is only a good thing when the time is right, however. After all, unrestrained cell multiplication leads to tumors. According to this report, Igf2 knows it's time to activate in the fluid because of proteins in long cells that surround the fluid. These long glial cells stretch from the inner part of the brain, where the fluid is, to its outer layer. They form early in brain development, and younger brain cells crawl along them during development as they find their appropriate positions like patrons filing into an opera house. At the innermost-end of the cells, at a spot called the apical domain, two proteins regulate Igf2 by altering other proteins at the surface of the glial cells, which bind to Ifg2.
If one of the steps in this pathway goes awry, Ifg2 could be activated at the wrong time causing uncontrolled proliferation. Indeed, brain cancer patients with the worst prognosis appear to have the highest levels of Igf2.
However, the fact that vital signals are sent from cerebrospinal fluid could be good news for cancer patients. "It's difficult to deliver a drug that will influence a specific spot within the brain tissue," says LaMantia. Instead, clinicians might one day infuse brain fluid with medicine – possibly one that blocks the signals from Igf2 telling cells to proliferate. "The possibilities for using the fluid as an efficient mechanism to deliver small molecule drugs are endless," he says.
Stem cell researchers now have another possible mechanism to explore in regards to how stem cells in other parts of the body differentiate and multiply. Perhaps researchers might find important proteins in what was thought to be benign fluid associated with the lungs, intestines, or other organs.
Finally, the study contributes to research on schizophrenia, autism and other neurological disorders thought to result from an erroneous arrangement of brain cells. Researchers must learn how brain development goes awry before they can design treatments, and therefore they must know how brain cells proliferate and move to the right position normally.
"This study was a massive undertaking requiring multiple labs with different resources," says LaMantia. "This is a remarkable line of investigation, and there are enormous possibilities for future work in this area."
Funding for the study came from the National Institute of Child Health and Human Development.
About The George Washington University Medical Center
The George Washington University Medical Center is an internationally recognized interdisciplinary academic health center that has conducted scientific research and provided high-quality medical care in the Washington, D.C., metropolitan area since 1824. For more information about the GW Medical Center, visit: www.gwumc.edu
Anne Banner | EurekAlert!
Shrews shrink in winter and regrow in spring
24.10.2017 | Max-Planck-Institut für Ornithologie
'Y' a protein unicorn might matter in glaucoma
23.10.2017 | Georgia Institute of Technology
Salmonellae are dangerous pathogens that enter the body via contaminated food and can cause severe infections. But these bacteria are also known to target...
University of Maryland researchers contribute to historic detection of gravitational waves and light created by event
On August 17, 2017, at 12:41:04 UTC, scientists made the first direct observation of a merger between two neutron stars--the dense, collapsed cores that remain...
Seven new papers describe the first-ever detection of light from a gravitational wave source. The event, caused by two neutron stars colliding and merging together, was dubbed GW170817 because it sent ripples through space-time that reached Earth on 2017 August 17. Around the world, hundreds of excited astronomers mobilized quickly and were able to observe the event using numerous telescopes, providing a wealth of new data.
Previous detections of gravitational waves have all involved the merger of two black holes, a feat that won the 2017 Nobel Prize in Physics earlier this month....
Material defects in end products can quickly result in failures in many areas of industry, and have a massive impact on the safe use of their products. This is why, in the field of quality assurance, intelligent, nondestructive sensor systems play a key role. They allow testing components and parts in a rapid and cost-efficient manner without destroying the actual product or changing its surface. Experts from the Fraunhofer IZFP in Saarbrücken will be presenting two exhibits at the Blechexpo in Stuttgart from 7–10 November 2017 that allow fast, reliable, and automated characterization of materials and detection of defects (Hall 5, Booth 5306).
When quality testing uses time-consuming destructive test methods, it can result in enormous costs due to damaging or destroying the products. And given that...
Using a new cooling technique MPQ scientists succeed at observing collisions in a dense beam of cold and slow dipolar molecules.
How do chemical reactions proceed at extremely low temperatures? The answer requires the investigation of molecular samples that are cold, dense, and slow at...
23.10.2017 | Event News
17.10.2017 | Event News
10.10.2017 | Event News
24.10.2017 | Life Sciences
23.10.2017 | Life Sciences
23.10.2017 | Physics and Astronomy